Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer. - Rovithi M; Lind JS; Pham TV; Voortman J; Knol JC; Verheul HM; Smit EF; Jimenez CR (Proteomics. Clinical applications, 2016)